Ledger.Open graph →
SEC Form D · filed July 20, 2022

RYNE Biotechnology Inc

Offering
$5.0M
Sold
$3.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (11)

Jonathan Yeh · Cambridge, MAExec · DirectorNick Manusos · Cambridge, MAExec · DirectorHoward Federoff · Cambridge, MADirectorIgnacio Novoa · Brea, CAExec · DirectorDean Mai · Los Angeles, CADirectorDavis Treybig · Los Angeles, CAExec · DirectorCarter Cliff · Parker, CODirectorSpencer Hart · Dallas, TXDirectorRyan Waddington · A, MIExec · DirectorSusan V. Dinges · HOUSTON, TXExec · DirectorCarter Cliff · Parker, CODirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗